<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03464994</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/17/0067</org_study_id>
    <secondary_id>2017-A00605-48</secondary_id>
    <nct_id>NCT03464994</nct_id>
  </id_info>
  <brief_title>Ophthalmological Abnormalities in Hereditary Ichthyosis (ICHTYO-KERATO)</brief_title>
  <official_title>Prevalence of Ophthalmological Abnormalities in Children and Adults Suffering From Hereditary Ichthyosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Association for the development of research in Dermatology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Presence/absence of subclinical keratoconus with corneal topographic abnormalities (skewed&#xD;
      radial axes for forme fruste keratoconus, and inferior steepening for keratoconus suspect) on&#xD;
      axial specular topography (TMS-4 Tomey), and elevation topographies: Pentacam (Oculus) and&#xD;
      Orbscan (Bausch &amp; Lomb).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Hereditary ichthyosis are rare genetic diseases characterized by an abnormal&#xD;
      epithelial keratinization due to mutations in gene involved in skin barrier. Patients present&#xD;
      with scales on the whole body. Recent classification basically distinguishes syndromic from&#xD;
      non-syndromic forms. Ichthyoses are severe diseases with significant impact on quality of&#xD;
      life, due to troublesome symptoms (pruritus, pain), lack of effective therapy and&#xD;
      complications such as ophthalmological anomalies. Among ophthalmological abnormalities, some&#xD;
      are well known, such as eyelid abnormalities, including ectropion, and sicca syndrome.&#xD;
      Conversely, corneal abnormalities such as keratoconus are not or very partially described in&#xD;
      ichthyosis. The keratoconus is characterized by a corneal thickening and bulging with&#xD;
      progressive loss of vision that may require a corneal transplantation. Its prevalence is&#xD;
      0.05% in its symptomatic presentation but may reach 10% when considering subclinical&#xD;
      keratoconus diagnosed on basis of corneal topographies. These forme fruste keratoconus or&#xD;
      keratoconus suspect may remain subclinical or instead progress to severe keratoconus. Corneal&#xD;
      collagen crosslinking has been shown to strengthen the cornea in order to halt progressive&#xD;
      keratoconus, justifying the need for early screening. Keratoconus is a complex condition of&#xD;
      multifactorial etiology. With regards to the pathophysiology of the keratoconus, some&#xD;
      hypotheses incriminate the corneal epithelial differentiation that is similar to the&#xD;
      epidermal differentiation altered in ichthyosis. This link between both dermatological and&#xD;
      ophthalmological abnormalities is supported by clinical experience. It's was observed that&#xD;
      ichthyosis patients have frequently a subclinical keratoconus. In clinical practice,&#xD;
      ophthalmological abnormalities are not commonly investigated in ichthyosis patients and there&#xD;
      are no data on prevalence in the literature. Furthermore, there are no guidelines on&#xD;
      screening or therapy of ophthalmological abnormities in ichthyosis.&#xD;
&#xD;
      The purpose of this project is to demonstrate that the prevalence of subclinical keratoconus&#xD;
      (including forme fruste keratoconus and keratoconus suspect) is higher in ichthyosis compared&#xD;
      to healthy controls.&#xD;
&#xD;
      Descriptive analysis of the studied population for primary outcome: The proportion of&#xD;
      patients with subclinical keratoconus (including form fruste keratoconus and keratoconus&#xD;
      suspect) will be described in each study-group and compared between study-groups using Mac&#xD;
      Nemar Test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 18, 2017</start_date>
  <completion_date type="Anticipated">July 18, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 18, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence/absence of subclinical keratoconus</measure>
    <time_frame>10 mn</time_frame>
    <description>Presence/absence of subclinical keratoconus with corneal topographic abnormalities (skewed radial axes for forme fruste keratoconus, and inferior steepening for keratoconus suspect) on axial specular topography (TMS-4 Tomey), and elevation topographies: Pentacam (Oculus) and Orbscan (Bausch &amp; Lomb).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of symptomatic keratoconus with irregular topographic maps</measure>
    <time_frame>10 mn</time_frame>
    <description>Evaluation by corneal videotopographies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of an abnormality of corneal transparency</measure>
    <time_frame>10 mn</time_frame>
    <description>Evaluated by the measurement of the refraction,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of sicca syndrome</measure>
    <time_frame>10 mn</time_frame>
    <description>Examination with the slit lamp of eyelids and eyelashes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of quality of vision</measure>
    <time_frame>10 mn</time_frame>
    <description>-Ocular Surface Disease Index (OSDI) : Self administered form to evaluate the impact of dry eye on visual function : 12 questions rated from 0 (never) to 4 (all the time)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life for adults</measure>
    <time_frame>10 mn</time_frame>
    <description>-Quality of life by the National Eye Institute Visual Function Questionnaire (NEI-VFQ) : Self-administered questionnaire witch incorporates a wider range of data in relation to quality of life related to vision. Each question leads to an answer that is either dichotomous (yes / no), or graduated in 3, 4.5 and 6 points. The score of each item is transformed from 0 to 100, and the average of the scores by domain is established.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">152</enrollment>
  <condition>Ichthyosis</condition>
  <arm_group>
    <arm_group_label>ichthyosis patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients presenting an Hereditary ichthyosis, whatever form or ongoing therapy will have an ophthalmological examination.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control population</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patient without ichthyosis disease and consulting an ophthalmologist for refractive surgery screening or systematic eye examination will have an ophthalmological examination</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ophthalmological examination</intervention_name>
    <description>Refraction&#xD;
Best corrected visual acuity&#xD;
Intraocular pressure&#xD;
Slit lamp examination with vital dye (Oxford grading)&#xD;
Tear break-up time (TBUT)&#xD;
Schirmer I testing&#xD;
Specular (TMS-4 Tomey) and elevation (pentacam Oculus and Orbscan Bausch &amp; Lomb) corneal videotopographies&#xD;
Pachymetry&#xD;
Questionnaires: Ocular surface disease index, quality of vision (visual analogic scale), and quality of life (NEI-VFQ25)&#xD;
questionnaire about ichthyosis severity&#xD;
questionnaire about life quality specifically for patient presenting ichthyosis</description>
    <arm_group_label>control population</arm_group_label>
    <arm_group_label>ichthyosis patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        For ichthyosis population:&#xD;
&#xD;
          -  Hereditary ichthyosis, whatever form or ongoing therapy.&#xD;
&#xD;
          -  Parental permission for minors&#xD;
&#xD;
        For controls:&#xD;
&#xD;
          -  Patients who consult an ophthalmologist for refractive surgery screening or systematic&#xD;
             eye examination&#xD;
&#xD;
          -  Parental permission for minors&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        For both populations:&#xD;
&#xD;
          -  Patient who cannot stay seated&#xD;
&#xD;
          -  Wearing contact lens within the last 7 days&#xD;
&#xD;
          -  No social security&#xD;
&#xD;
          -  Past medical history of corneal or eye surgery or eye condition (glaucoma, uveitis,&#xD;
             keratoconus, retinal diseases)&#xD;
&#xD;
          -  Impossibility to fill the questionnaires&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juliette MAZEREEUW, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juliette MAZEREEUW, MD</last_name>
    <phone>05 67 77 81 41</phone>
    <phone_ext>33</phone_ext>
    <email>mazereeuw-hautier.j@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>OLIVIER Isabelle, PhD</last_name>
    <phone>05 61 77 70 51</phone>
    <phone_ext>33</phone_ext>
    <email>olivier.i@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juliette MAZEREEUW, MD</last_name>
      <phone>05 67 77 81 41</phone>
      <phone_ext>33</phone_ext>
      <email>mazereeuw-hautier.j@chu-toulouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Isabelle OLIVIER, PhD</last_name>
      <phone>05-61-77-70-51</phone>
      <phone_ext>33</phone_ext>
      <email>olivier.i@chu-toulouse.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <study_first_submitted>November 18, 2017</study_first_submitted>
  <study_first_submitted_qc>March 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2018</study_first_posted>
  <last_update_submitted>March 7, 2018</last_update_submitted>
  <last_update_submitted_qc>March 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hereditary ichthyosis</keyword>
  <keyword>keratoconus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ichthyosis</mesh_term>
    <mesh_term>Ichthyosis, Lamellar</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

